Iodide

Iodide

SCHEMBL4213036

CN1C=CN(c2ccc(C#N)cc2)C1.I

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.41
KDM4E B2RXH2 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.39
CHEK1 O14757 1/20 0.38
CYP2A6 P11509 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CHRNA10 Q9GZZ6 1/20 0.37
CHRNA9 Q9UGM1 1/20 0.37
RAB9A P51151 1/20 0.36
KCNH2 Q12809 2/20 0.36
KCNJ1 P48048 1/20 0.36
ELANE P08246 1/20 0.36
HDAC8 Q9BY41 1/20 0.35
KIF11 P52732 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13876041 0.98 HRH3 (0.42) HRH3KDM4ETP53POLBCHEK1
SCHEMBL30639263 0.85 KDM4E (0.47) HRH3KDM4ETP53POLBCHEK1
Ammonia Solution, Strong SCHEMBL30639264 0.83 KDM4E (0.46) HRH3KDM4ETP53POLBCHEK1
Hydrochloric Acid SCHEMBL28679874 0.83 KDM4E (0.46) HRH3KDM4ETP53POLBCHEK1
SCHEMBL27894883 0.80 ALDH1A1 (0.59) HRH3KDM4ETP53POLBCHEK1
Iodide SCHEMBL2530875 0.79
SCHEMBL28288408 0.78 TSHR (0.48) HRH3KDM4ETP53POLB
Hydrochloric Acid SCHEMBL28561999 0.75 KDM4E (0.40) HRH3KDM4ETP53POLBCHEK1
Thiocyanic Acid SCHEMBL27709180 0.75 MAPT (0.32)
Iodide SCHEMBL3820109 0.75 MAPT (0.36) POLBRAB9AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877937-B2 Process for preparing transition metal-carbene complexes BASF SE (DE) 2014-11-04 US disclosed
US-20130178621-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES BASF SE (DE) 2013-07-11 US disclosed
US-8410280-B2 Process for preparing transition metal-carbene complexes BASF SE (DE) 2013-04-02 US disclosed
US-20090018330-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES BASF SE (DE) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018330-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES AP1M1, C1S, GPS1 HRH3 867/4885KDM4E 4586/4885TP53 651/4885
US-20130178621-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES AP1M1, C1S, GPS1 HRH3 867/4885KDM4E 4586/4885TP53 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.